Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-02-23 @ 9:22 PM
Study NCT ID:
NCT05499260
Status:
UNKNOWN
Last Update Posted:
2022-08-16
First Post:
2022-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants
Sponsor:
Shanghai Zhimeng Biopharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-03-02
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-08
First Submit QC Date:
None
Study First Post Date:
2022-08-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-14
Last Update Post Date:
2022-08-16
Last Update Post Date Type:
ACTUAL